How Toll-like receptors signal: What we know and what we don't know

Current Opinion in Immunology

Volumn 18, Issue 1, 2006, Pages 3-9

  O'Neill, Luke A J ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; ALPHA INTERFERON; BETA INTERFERON; CD14 ANTIGEN; CD36 ANTIGEN; CYTOKINE; GLUCOCORTICOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 5; INTERFERON REGULATORY FACTOR 7; INTERLEUKIN 6; LEUCINE; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN MAL; PROTEIN SARM; PROTEIN TIR RELATED ADAPTOR PROTEIN INDUCING INTERFERON; PROTEIN TRIF RELATED ADAPTOR MOLECULE; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 9; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; VIRUS PROTEIN;

DRUG INHIBITION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; NONHUMAN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; COMMUNICABLE DISEASES; HUMANS; INFLAMMATION; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS; TRANSCRIPTION FACTORS;

EID: 30044442866     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2005.11.012     Document Type: Review

References (46)

1. L.A. O'Neill Immunity's early warning system Sci Am 292 2005 24 31
2. F. Yarovinsky, D. Zhang, J.F. Anderson, G.L. Bannenberg, C.N. Serhan, M.S. Hayden, S. Hieny, F.S. Sutterwala, R.A. Flavell, S. Ghosh, and A. Sher TLR11 activation of dendritic cells by a protozoan profilin-like protein Science 308 2005 1626 1629
3. A.F. McGettrick, and L.A.J. O'Neill The expanding family of MyD88-like adapters in TLR signal transduction Mol Immunol 41 2004 577 582
4. L.A.J. O'Neill, K.A. Fitzgerald, and A.G. Bowie The Toll/IL-1 receptor adapter family grows to 5 members Trends Immunol 24 2003 286 290
5. A.N. Weber, M.C. Moncrieffe, M. Gangloff, J.L. Imler, and N.J. Gay Ligand-receptor and receptor-receptor interactions act in concert to activate signaling in the Drosophila toll pathway J Biol Chem 280 2005 22793 22799
6. K.A. Fitzgerald, E.M. Palsson-McDermott, A.G. Bowie, C. Jeffries, A. Mansell, G. Brady, E. Brint, A. Dunne, P. Gray, and M. Harte Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction Nature 413 2001 78 83
7. T. Horng, G.M. Barton, and R.L. Medzhitov TIRAP: an adapter molecule in the Toll signaling pathway Nat Immunol 2 2001 835 841
8. M. Yamamoto, S. Sato, H. Hemmi, H. Sanjo, S. Uematsu, T. Kaisho, K. Hoshino, O. Takeuchi, M. Kobayashi, and T. Fujita Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4 Nature 420 2002 324 329
9. T. Horng, G.M. Barton, R.A. Flavell, and R. Medzhitov The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors Nature 420 2002 329 333
10. M. Yamamoto, S. Sato, K. Mori, K. Hoshino, O. Takeuchi, K. Takeda, and S. Akira A novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling J Immunol 169 2002 6668 6672
11. H. Oshiumi, M. Matsumoto, K. Funami, T. Akazawa, and T. Seya TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction Nat Immunol 4 2003 161 167
12. K. Hoebe, X. Du, P. Georgel, E. Janssen, K. Tabeta, S.O. Kim, J. Goode, P. Lin, N. Mann, and S. Mudd Identification of Lps2 as a key transducer of MyD88-independent TIR signalling Nature 424 2003 743 748
13. K.A. Fitzgerald, S.M. McWhirter, K.L. Faia, D.C. Rowe, E. Latz, D.T. Golenbock, A.J. Coyle, S.M. Liao, and T. Maniatis IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway Nat Immunol 4 2003 491 496
14. K.A. Fitzgerald, D.C. Rowe, B.J. Barnes, D.R. Caffrey, A. Visintin, E. Latz, B. Monks, P.M. Pitha, and D.T. Golenbock LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF J Exp Med 198 2003 1043 1055
15. H. Oshiumi, M. Sasai, K. Shida, T. Fujita, M. Matsumoto, and T. Seya TIR-containing adapter molecule (TICAM)-2, a bridging adapter recruiting to toll-like receptor 4 TICAM-1 that induces interferon-beta J Biol Chem 278 2003 49751 49762
16. M. Yamamoto, S. Sato, H. Hemmi, S. Uematsu, K. Hoshino, T. Kaisho, O. Takeuchi, K. Takeda, and S. Akira TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway Nat Immunol 4 2003 1144 1150
17. Y. Xu, X. Tao, B. Shen, T. Horng, R. Medzhitov, J.L. Manley, and L. Tong Structural basis for signal transduction by the Toll/interleukin-1 receptor domains Nature 408 2000 111 115
18. J.A. Khan, E.K. Brint, L.A. O'Neill, and L. Tong Crystal structure of the Toll/interleukin-1 receptor domain of human IL-1RAPL J Biol Chem 279 2004 31664 31670
19. T.P. Hopp Evidence from sequence information that the interleukin-1 receptor is a transmembrane GTPase Protein Sci 4 1995 1851 1859
20. A. Poltorak, X. He, I. Smirnova, M.Y. Liu, C. Van Huffel, X. Du, D. Birdwell, E. Alejos, M. Silva, and C. Galanos Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene Science 282 1998 2085 2088
21. A. Dunne, M. Ejdeback, P.L. Ludidi, L.A. O'Neill, and N.J. Gay Structural complementarity of Toll/Interleukin1 receptor identity regions in toll-like receptors and the adaptors Mal and MyD88 J Biol Chem 278 2003 41443 41451
22. C. Li, J. Zienkiewicz, and J. Hawiger Interactive sites in the MyD88 Toll/interleukin (IL) 1 receptor domain responsible for coupling to the IL1beta signaling pathway J Biol Chem 280 2005 26152 26159
23. T. Bartfai, M.M. Behrens, S. Gaidarova, J. Pemberton, A. Shivanyuk, and J. Rebek Jr. A low molecular weight mimic of the Toll/IL-1 receptor/resistance domain inhibits IL-1 receptor-mediated responses Proc Natl Acad Sci USA 100 2003 7971 7976
24. J. Choe, M.S. Kelker, and I.A. Wilson Crystal structure of human toll-like receptor 3 (TLR3) ectodomain Science 309 2005 581 585 The first published structure of the ectodomain of a TLR.
25. J.K. Bell, I. Botos, P.R. Hall, J. Askins, J. Shiloach, D.M. Segal, and D.R. Davies The molecular structure of the Toll-like receptor 3 ligand-binding domain Proc Natl Acad Sci USA 102 2005 10976 10980
26. T. Kawai, O. Takeuchi, T. Fujita, J. Inoue, P.F. Muhlradt, S. Sato, K. Hoshino, and S. Akira Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes J Immunol 167 2001 5887 5894
27. •].
28. • ] use computer modelling to examine NF-κB activation by LPS and uncover an autocrine loop activated by TNF which stabilizes the activation pathway.
29. Z. Jiang, P. Georgel, X. Du, L. Shamel, S. Sovath, S. Mudd, M. Huber, C. Kalis, S. Keck, and C. Galanos CD14 is required for MyD88-independent LPS signaling Nat Immunol 6 2005 565 570 CD14 is shown to enable access to the MyD88-independent signalling pathway, involving Trif and Tram, and activated by TLR4 in response to 'rough' LPS.
30. K. Hoebe, P. Georgel, S. Rutschmann, X. Du, S. Mudd, K. Crozat, S. Sovath, L. Shamel, T. Hartung, U. Zahringer, and B. Beutler CD36 is a sensor of diacylglycerides Nature 433 2005 523 527
31. K. Honda, Y. Ohba, H. Yanai, H. Negishi, T. Mizutani, A. Takaoka, C. Taya, and T. Taniguchi Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction Nature 434 2005 1035 1040 This paper provides an explanation of how TLR9 can induce IFN-α via stable recruitment of MyD88 to endosomes.
32. ••].
33. •• ] demonstrate the IRAK-1/MyD88-dependent activation of IRF7.
34. E. Brint, D. Xu, H. Liu, A. Dunne, A. McKenzie, L.A.J. O'Neill, and F.Y. Liew ST2 is an inhibitor of IL-1R and TLR4 signalling and maintains endotoxin tolerance Nat Immunol 5 2004 373 379
35. K. Burns, S. Janssens, B. Brissoni, N. Olivos, R. Beyaert, and J. Tschopp Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4 J Exp Med 197 2003 263 268
36. Y. Naiki, K.S. Michelsen, W. Zhang, S. Chen, T.M. Doherty, and M. Arditi Transforming growth factor-beta differentially inhibits MyD88-dependent, but not TRAM- and TRIF-dependent, lipopolysaccharide-induced TLR4 signaling J Biol Chem 280 2005 5491 5495
37. A. Bowie, E. Kiss-Toth, J.A. Symons, G.L. Smith, S.K. Dower, and L.A.J. O'Neill A46R and A52R from vaccinia virus are antagonists of host IL-1 and Toll-like receptor signalling Proc Natl Acad Sci USA 97 2000 10162 10167
38. J. Stack, I.R. Haga, M. Schroder, N.W. Bartlett, G. Maloney, P.C. Reading, K.A. Fitzgerald, G.L. Smith, and A.G. Bowie Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence J Exp Med 201 2005 1007 1018 This paper demonstrates how Vaccinia virus, via A46R, can block multiple TLRs by sequestering adapters.
39. K. Li, E. Foy, J.C. Ferreon, M. Nakamura, A.C. Ferreon, M. Ikeda, S.C. Ray, M. Gale Jr., and S.M. Lemon Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF Proc Natl Acad Sci USA 102 2005 2992 2997 This paper provides a possible explanation for the persistence of hepatitis C virus via proteolysis of Trif.
40. T. Kawai, S. Sato, K.J. Ishii, C. Coban, H. Hemmi, M. Yamamoto, K. Terai, M. Matsuda, J. Inoue, and S. Uematsu Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6 Nat Immunol 5 2004 1061 1068
41. X. Li, M. Commane, C. Burns, K. Vithalani, Z. Cao, and G.R. Stark Mutant cells that do not respond to interleukin-1 (IL-1) reveal a novel role for IL-1 receptor-associated kinase Mol Cell Biol 19 1999 4643 4652
42. J.L. Swantek, M.F. Tsen, M.H. Cobb, and J.A. Thomas IL-1 receptor-associated kinase modulates host responsiveness to endotoxin J Immunol 164 2000 4301 4306
43. A. Takaoka, H. Yanai, S. Kondo, G. Duncan, H. Negishi, T. Mizutani, S. Kano, K. Honda, Y. Ohba, T.W. Mak, and T. Taniguchi Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors Nature 434 2005 243 249 IRF5 is identified as a key transcription factor activated by TLRs.
44. M. Yamamoto, S. Yamazaki, S. Uematsu, S. Sato, H. Hemmi, K. Hoshino, T. Kaisho, H. Kuwata, O. Takeuchi, and K. Takeshige Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein IkappaBzeta Nature 430 2004 218 222
45. ••].
46. •• ] describe how TLR4 differs from TLR3 in terms of ISRE activation and how the IRF3-p65 complex activated by TLR4 is a key target for inhibition by glucocorticoids.